Ditchcarbon
  • Contact
  1. Organizations
  2. HanchorBio Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
TW
updated 2 months ago

HanchorBio Inc. Sustainability Profile

Company website

HanchorBio Inc., a leading biotechnology firm headquartered in Taiwan (TW), has been at the forefront of innovative solutions since its establishment. Specialising in advanced biopharmaceuticals and cutting-edge research, the company operates primarily in the Asia-Pacific region, with a growing presence in global markets. Founded in 2015, HanchorBio has achieved significant milestones, including the development of unique therapeutic products that address unmet medical needs. Their core offerings, which include monoclonal antibodies and biologics, are distinguished by their precision and efficacy, setting new standards in the industry. With a strong commitment to research and development, HanchorBio has positioned itself as a key player in the biopharmaceutical landscape, recognised for its contributions to healthcare advancements and patient outcomes.

DitchCarbon Score

How does HanchorBio Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

20

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

HanchorBio Inc.'s score of 20 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.

22%

Let us know if this data was useful to you

HanchorBio Inc.'s reported carbon emissions

HanchorBio Inc., headquartered in Taiwan (TW), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, HanchorBio Inc. has not established any significant climate commitments or initiatives to reduce its carbon footprint. The lack of emissions data and reduction strategies suggests that the company may still be in the early stages of developing its climate action framework. In the context of the industry, it is essential for companies to adopt robust climate commitments and transparent reporting practices to align with global sustainability goals. HanchorBio Inc. may benefit from exploring industry-standard initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP) to enhance its climate strategy in the future.

How Carbon Intensive is HanchorBio Inc.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. HanchorBio Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is HanchorBio Inc.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for HanchorBio Inc. is in TW, which we do not have grid emissions data for.

HanchorBio Inc.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

HanchorBio Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare HanchorBio Inc.'s Emissions with Industry Peers

Sumgen Biotech

CN
Updated about 2 months ago

Merck And Co

US
•
Pharmaceutical Preparation Manufacturing
Updated about 5 hours ago

Regeneron

US
•
Pharmaceutical Preparation Manufacturing
Updated 15 days ago

Illumina

US
•
Research and development services (73)
Updated 11 days ago

Amgen

US
•
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Johnson And Johnson

US
•
Pharmaceutical Preparation Manufacturing
Updated about 20 hours ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251031.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy